Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perspective
  • Published:

Cure therapeutics and strategic prevention: raising the bar for mental health research

Molecular Psychiatry volume 11, pages 11–17 (2006)Cite this article

Abstract

Mental disorders cause more disability than any other class of medical illness in Americans between ages 15 and 44 years. The suicide rate is higher than the annual mortality from homicide, AIDS, and most forms of cancer. In contrast to nearly all communicable and most non-communicable diseases, there is little evidence that the morbidity and mortality from mental disorders have changed in the past several decades. Mental health advocates, including psychiatric researchers, have pointed to stigma as one of the reasons for the lack of progress with mental illnesses relative to other medical illnesses. This review considers how the expectations and goals of the research community have contributed to this relative lack of progress. In contrast to researchers in cancer and heart disease who have sought cures and preventions, biological psychiatrists in both academia and industry have set their sights on incremental and marketable advances, such as drugs with fewer adverse effects. This essay argues for approaches that can lead to cures and strategies for prevention of schizophrenia and mood disorders.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Kennedy M . A Brief History of Disease, Science and Medicine, The Writers Collective, Cranston, Rhode Island, 2004.

  2. Zerhouni E . Translational and clinical science–time for a new vision. N Engl J Med 2005; 353: 1621–1623.

    Article  CAS  Google Scholar 

  3. Kessler RC, Chiu W, Demler O, Walters E . Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication (NCS-R). Arch Gen Psychiatr 2005; 62: 617–627.

    Article  Google Scholar 

  4. Lauriello J, Bustillo JR, Keith SJ . Schizophrenia: scope of the problem. In: Sadock BJ, Sadock VA (eds). Comprehensive Textbook of Psychiatry, 8th edn. Lippincott Williams & Wilkins: Philadelphia, 2004, pp 1345–1353.

    Google Scholar 

  5. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C . Prevalence of autism in a US metropolitan area. JAMA 2003; 289: 49–55.

    Article  Google Scholar 

  6. WHO Report. 2002; http://www.who.int/healthinfo/bodestimates/en/.

  7. Goldsmith SK, Pellmar TC, Kleinman AM, Bunney WE (eds). Reducing Suicide: A National Imperative. Board on Neuroscience and Behavioral Health, Institute of Medicine Publisher: Washington, DC, 2002.

    Google Scholar 

  8. Heila H, Haukka J, Suvisaari J, Lonnqvist J . Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med 2005; 35: 725–732.

    Article  Google Scholar 

  9. Keel PK, Dorer DJ, Eddy KT, Franko D, Charatan DL, Herzog DB . Predictors of mortality in eating disorders. Arch Gen Psychiatr 2003; 60: 179–183.

    Article  Google Scholar 

  10. Kessler R, Berglund P, Demler O, Jin R, Koretz D, Merikangas K et al. The epidemiology of major depressive disorder. JAMA 2003; 289: 3095–3105.

    Article  Google Scholar 

  11. Lehman AF, Steinwachs DM . Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) client survey. Schizophr Bull 1998; 24: 11–20.

    Article  CAS  Google Scholar 

  12. McFarlane WR, Dixon L, Lukens E, Lucksted A . Family psychoeducation and schizophrenia: a review of the literature. J Marital Fam Ther 2003; 29: 223–245.

    Article  Google Scholar 

  13. Resnick SG, Rosenheck HA, Dixon L, Lehman AF . Correlates of family contact with the mental health system: allocation of a scare resource. Ment Health Serv Res 2005; 2: 113–121.

    Article  Google Scholar 

  14. The President's New Freedom Commission on Mental Health. Achieving the Promise: transforming mental health care in America, Final Report, July 2003.

  15. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch of Gen Psychiatr 1991; 48: 851–885.

    Article  CAS  Google Scholar 

  16. Nierenberg AA, Wright EC . Evolution of remission as the new standard in the treatment of depression. J Clin Psychiatr 1999; 60 (Suppl 22): 7–11.

    Google Scholar 

  17. Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR . Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatr 2005; 162: 441–449.

    Article  Google Scholar 

  18. Resnick S, Rosenbeck R, Lehman A . An exploratory analysis of correlates of recovery. Psychiatr Serv 2004; 55: 540–547.

    Article  Google Scholar 

  19. Hyman S, Fenton W . Medicine. What are the right targets for psychopharmacology? Science 2003; 299: 350–351.

    Article  CAS  Google Scholar 

  20. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209–1223.

    Article  CAS  Google Scholar 

  21. Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM . Symptomatic and functional recovery from a first episode of schizophrenia. Am J Psychol 2004; 161: 473–479.

    Article  Google Scholar 

  22. Tamminga C, Nemeroff C, Blakely R, Brady L, Carter C, Davis K et al. Developing novel treatments for mood disorders: accelerating discovery. Biol Psychiatr 2002; 52: 589–609.

    Article  Google Scholar 

  23. Trivedi M, Rush J, Wisniewski S, Nierenberg A, Warden D, Ritz L et al. Outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical research and practice. Am J Psychiatr, in press.

  24. Zipursky RB, Christensen BK, Daskalakis Z, Epstein I, Roy P, Furimsky I et al. Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis. Can J Psychiatr 2005; 50: 462–469.

    Article  Google Scholar 

  25. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H. et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386–389.

    Article  CAS  Google Scholar 

  26. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B . The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatr 2005; 62: 529–535.

    Article  CAS  Google Scholar 

  27. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005; 6: 828–834.

    Article  Google Scholar 

  28. The International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 436: 1299–1320.

  29. Edwards AO, Ritter R, Abel K, Manning A, Panhuysen C, Farrer L . Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308: 421–424.

    Article  CAS  Google Scholar 

  30. Austin C, Brady L, Insel T, Collins F . Molecular biology: NIH molecular libraries initiative. Science 2004; 306: 1138–1139.

    Article  CAS  Google Scholar 

  31. Billings LM, Oddo S, Green KN, McGaugh JL, Laferla FM . Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 2005; 45: 675–688.

    Article  CAS  Google Scholar 

  32. Zarnescu DC, Shan G, Warren ST, Jin P . Come fly with us: toward understanding fragile X syndrome. Genes Brain Beh 2005; 6: 385–392.

    Article  Google Scholar 

  33. Neul J, Zoghbi H . Rett syndrome: a prototypical neurodevelopmental disorder. Neuroscientist 2004; 10: 118–128.

    Article  CAS  Google Scholar 

  34. Druker BJ . Imatinib as a paradigm of targeted therapies. Adv Cancer Res 2004; 91: 1–30.

    Article  CAS  Google Scholar 

  35. Olds D, Henderson C, Cole R, Eckenrode J, Kitzman H, Luckey D et al. Long-term effects of nurse home visitation on children's criminal and antisocial behavior. JAMA 1998; 280: 1238–1244.

    Article  CAS  Google Scholar 

  36. Owens C, Miller P, Lawrie S, Johnstone E . Pathogenesis of schizophrenia: a psychopathological perspective. Br J Psychiatr 2005; 186: 386–393.

    Article  Google Scholar 

  37. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane SM, Hallgren M et al. Psychosis prediction: 12-month follow up of a high risk (‘prodromal’) group. Schizophr Res 2003; 60: 21–32.

    Article  Google Scholar 

  38. Segman RH, Gtoltser-Dubner T, Friedman N, Kaminski N, Shalev A . Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol Psychiatr 2005; 10: 500–513.

    Article  CAS  Google Scholar 

  39. Yehuda R, Bryant R, Marmar C, Zohar J . Pathological responses to terrorism. Neuropsychopharmacology 2005; 30: 1793–1805.

    Article  Google Scholar 

  40. Foa EB, Cahill SP, Boscarino JA, Hobfoll SE, Lahad M, McNally RJ et al. Social, psychological, and psychiatric interventions following terrorist attacks: recommendations for practice and research. Neuropsychopharmacology 2005; 30: 1806–1817.

    Article  Google Scholar 

  41. Nemeroff C, Bremner JD, Foa EB, Mayberg HS, North CS, Stein MB . Posttraumatic stress disorder: a state-of-the-science review. J Psychiatr Res 2005, in press.

Download references

Author information

Authors and Affiliations

  1. NIMH, Bethesda, MD, USA

    T R Insel

  2. Broad Institute of MIT and Harvard, Cambridge, MA, USA

    E M Scolnick

Authors
  1. T R Insel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E M Scolnick
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T R Insel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Insel, T., Scolnick, E. Cure therapeutics and strategic prevention: raising the bar for mental health research. Mol Psychiatry 11, 11–17 (2006). https://doi.org/10.1038/sj.mp.4001777

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001777

Keywords

This article is cited by

Search

Advanced search

Quick links